Your browser doesn't support javascript.
loading
Proposal for a regulation on health technology assessment in Europe - opinions of policy makers, payers and academics from the field of HTA.
Vella Bonanno, Patricia; Bucsics, Anna; Simoens, Steven; Martin, Antony P; Oortwijn, Wija; Gulbinovic, Jolanta; Rothe, Celia; Timoney, Angela; Ferrario, Alessandra; Gad, Mohamed; Salem, Ahmed; Hoxha, Iris; Sauermann, Robert; Kamusheva, Maria; Dimitrova, Maria; Petrova, Guenka; Laius, Ott; Selke, Gisbert; Kourafalos, Vasilios; Yfantopoulos, John; Magnusson, Einar; Joppi, Roberta; Jakupi, Arianit; Bochenek, Tomasz; Wladysiuk, Magdalene; Furtado, Claudia; Markovic-Pekovic, Vanda; Mardare, Ileana; Meshkov, Dmitry; Fürst, Jurij; Tomek, Dominik; Cortadellas, Merce Obach; Zara, Corrine; Haycox, Alan; Campbell, Stephen; Godman, Brian.
Afiliación
  • Vella Bonanno P; a Strathclyde Institute of Pharmacy and Biomedical Sciences , University of Strathclyde , Glasgow , UK.
  • Bucsics A; b Mechanism of Coordinated Access to Orphan Medicinal Products (MoCA) , Brussels , Belgium.
  • Simoens S; c KU Leuven Department of Pharmaceutical and Pharmacological Sciences , Leuven , Belgium.
  • Martin AP; d Health Economics Centre , University of Liverpool Management School , Liverpool , UK.
  • Oortwijn W; e Department for Health Evidence , Radboud University Medical Center , Nijmegen , The Netherlands.
  • Gulbinovic J; f Department of Pathology, Forensic Medicine and Pharmacology , Institute of Biomedical Sciences, Faculty of Medicine, VilniusUniversity , Vilnius , Lithuania.
  • Rothe C; g Department of Drug Management, Faculty of Health Sciences , Jagiellonian University Medical College , Krakow , Poland.
  • Timoney A; a Strathclyde Institute of Pharmacy and Biomedical Sciences , University of Strathclyde , Glasgow , UK.
  • Ferrario A; h NHS Lothian , Edinburgh , UK.
  • Gad M; i Division of Health Policy and Insurance Research, Department of Population Medicine , Harvard Medical School and Harvard Pilgrim Health Care Institute , Boston , MA , USA.
  • Salem A; j Global Health and Development Group , Imperial College , London , UK.
  • Hoxha I; k IQVIA , Brussels , Belgium.
  • Sauermann R; l Department of Pharmacy, Faculty of Medicine , University of Medicine , Tirana , Albania.
  • Kamusheva M; m Hauptverband der ÖsterreichischenSozialversicherungsträger , Vienna , Austria.
  • Dimitrova M; n Department of Organization and Economics of Pharmacy, Faculty of Pharmacy , Medical University-Sofia , Bulgaria.
  • Petrova G; n Department of Organization and Economics of Pharmacy, Faculty of Pharmacy , Medical University-Sofia , Bulgaria.
  • Laius O; n Department of Organization and Economics of Pharmacy, Faculty of Pharmacy , Medical University-Sofia , Bulgaria.
  • Selke G; o State Agency of Medicines , Tartu , Estonia.
  • Kourafalos V; p Wissenschaftliches Institut der AOK (WidO) , Berlin , Germany.
  • Yfantopoulos J; q EOPYY-National Organization for the Provision of Healthcare Services , Athens , Greece.
  • Magnusson E; r School of Economics and Political Science , University of Athens , Athens , Greece.
  • Joppi R; s Department of Health Services , Ministry of Health , Reykjavík , Iceland.
  • Jakupi A; t Pharmaceutical Drug Department , Azienda Sanitaria Locale of Verona , Verona , Italy.
  • Bochenek T; u UBT - Higher Education Institute , Prishtina , Kosovo.
  • Wladysiuk M; g Department of Drug Management, Faculty of Health Sciences , Jagiellonian University Medical College , Krakow , Poland.
  • Furtado C; v HTA Consulting , Cracow , Poland.
  • Markovic-Pekovic V; w Pharmaceutical Division , INFAMED , Lisbon , Portugal.
  • Mardare I; x Ministry of Health and Social Welfare , Banja Luka , Republic of Srpska, Bosnia and Herzegovina.
  • Meshkov D; y Department of Social Pharmacy , University of Banja Luka, Faculty of Medicine , Banja Luka , Republic of Srpska, Bosnia and Herzegovina.
  • Fürst J; z Faculty of Medicine, Public Health and Management Department , "Carol Davila" University of Medicine and Pharmacy Bucharest , Bucharest , Romania.
  • Tomek D; aa National Research Institution for Public Health , Moscow , Russia.
  • Cortadellas MO; ab Health Insurance Institute , Ljubljana , Slovenia.
  • Zara C; ac Faculty of Medicine, Slovak Medical University , Bratislava , Slovakia .
  • Haycox A; ad Drug Territorial Action Unit , Catalan Health Service , Barcelona , Spain.
  • Campbell S; ad Drug Territorial Action Unit , Catalan Health Service , Barcelona , Spain.
  • Godman B; d Health Economics Centre , University of Liverpool Management School , Liverpool , UK.
Expert Rev Pharmacoecon Outcomes Res ; 19(3): 251-261, 2019 Jun.
Article en En | MEDLINE | ID: mdl-30696372
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Formulación de Políticas / Evaluación de la Tecnología Biomédica / Política de Salud Tipo de estudio: Health_technology_assessment Límite: Humans Idioma: En Revista: Expert Rev Pharmacoecon Outcomes Res Asunto de la revista: FARMACOLOGIA Año: 2019 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Formulación de Políticas / Evaluación de la Tecnología Biomédica / Política de Salud Tipo de estudio: Health_technology_assessment Límite: Humans Idioma: En Revista: Expert Rev Pharmacoecon Outcomes Res Asunto de la revista: FARMACOLOGIA Año: 2019 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Reino Unido